P329: HIGH IMMUNOPROTEASOME ACTIVITY AS NOVEL INDICATOR FOR SENSITIVITY TO BORTEZOMIB-CONTAINING CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS FROM CHILDREN’S ONCOLOGY GROUP TRIAL AALL1231

Detalles Bibliográficos
Autores principales: Roeten, Margot, van Dijk, Suzanne, van Meerloo, Johan, Kwidama, Zinia, Jenkins, Gaya, Teachey, David, Devidas, Meenakshi, Loh, Mignon, Kaspers, Gertjan, Zweegman, Sonja, Jansen, Gerrit, Horton, Terzah, Cloos, Jacqueline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428354/
http://dx.doi.org/10.1097/01.HS9.0000968228.81299.a0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428354/
http://dx.doi.org/10.1097/01.HS9.0000968228.81299.a0

Ejemplares similares